Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

NCT04981795

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • University of California, Irvine Medical Center Orange, California, United States
  • McFarland Clinic P.C. Ames, Iowa, United States
View all 26 locations
View Trial Details
Completed

Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas

NCT02783625

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Washington School of Medicine in St. Louis St Louis, Missouri, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

NCT04673617

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Artiva Clinical Trial Site Birmingham, Alabama, United States
  • Artiva Clinical Trial Site Tucson, Arizona, United States
  • Artiva Clinical Trial Site Orange, California, United States
  • Artiva Clinical Trial Site San Diego, California, United States
View all 21 locations
View Trial Details
Completed

Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma

NCT00428142

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • BCCA - Vancouver Island Cancer Centre Victoria, British Columbia, Canada
View all 19 locations
View Trial Details
Completed

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

NCT05510908

Conditions
AIDS Related Lymphoma, AIDS-Related Kaposi Sarcoma, AIDS-Related Malignancy, +58 more
Locations
  • Moores UCSD Cancer Center La Jolla, California, United States
  • George Washington University Cancer Center Washington D.C., District of Columbia, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 16 locations
View Trial Details

Related conditions